Education
About Us
Working with TipRanks
Follow Us
Autolus Therapeutics Plc (AUTL)
NASDAQ:AUTL
Earnings Data
Report Date
Mar 10, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.23Last Year’s EPS
-0.09Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
While the company has seen a successful launch of Obe-cel in the U.S. with significant market penetration and expansion into new clinical areas, financial challenges such as high cost of sales and increased operational losses present notable challenges. However, the company is well-capitalized to continue its growth and expansion strategies.Company Guidance
Successful Launch of Obe-cel in the U.S.
Achieved $21.1 million in net sales in the third quarter, with a total of $51 million in sales in the first nine months. Established 60 authorized centers across the U.S. with a manufacturing success rate well above 90%.
Strong Market Penetration and Growth Potential
CAR T market share increased to approximately 20% in active centers. Significant opportunity for growth within existing centers and geographic expansion.
Clinical Trials and Pipeline Expansion
Initiated a pivotal phase two study in pediatric ALL, a phase two study in lupus nephritis, and an exploratory phase one study in progressive multiple sclerosis.
Positive Financial Position
The company remains well-capitalized with cash, cash equivalents, and marketable securities totaling $36.067 billion as of September 30, 2025.
AUTL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AUTL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 12, 2025 | $1.50 | $1.36 | -9.33% |
Aug 12, 2025 | $2.47 | $2.16 | -12.55% |
May 08, 2025 | $1.23 | $1.35 | +9.76% |
Mar 20, 2025 | $1.94 | $1.68 | -13.40% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Autolus Therapeutics Plc (AUTL) report earnings?
Autolus Therapeutics Plc (AUTL) is schdueled to report earning on Mar 10, 2026, Before Open (Confirmed).
What is Autolus Therapeutics Plc (AUTL) earnings time?
Autolus Therapeutics Plc (AUTL) earnings time is at Mar 10, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AUTL EPS forecast?
AUTL EPS forecast for the fiscal quarter 2025 (Q4) is -0.23.